ICMR revises strategy, to test people from hotspot areas having symptomatic influenza-like illness

Image
Press Trust of India New Delhi
Last Updated : Apr 09 2020 | 11:00 PM IST

Revising its strategy to fight the spread of COVID-19, the Indian Council of Medical Research (ICMR) on Thursday said people having symptoms like fever, cough, sore throat and runny nose and residing in hotspots or cluster areas and in evacuee centres will now be tested for coronavirus infection.

Till now, all hospitalised patients with severe acute respiratory illness, shortness of breath and having fever and cough were being tested for COVID-19 infection.

Also, asymptomatic direct and high-risk contacts of a confirmed case are also tested once between day 5 and day 14 of coming in his or her contact.

Besides, all asymptomatic individuals who undertook international travel in the last 14 days and developed symptoms, all symptomatic contacts of laboratory-confirmed cases and all symptomatic health care workers were being tested for the infection as per the guidelines.

In hotspots or clusters and in large migration gatherings and evacuee centres, all symptomatic influenza-like illness (fever, cough, sore throat, runny nose) will be tested for rRT-PCR within 7 days of illness and after 7 days of illness antibody test will be conductedif negative, confirmed by real-time reverse transcription polymerase chain reaction or rRT-PC test.

The apex body for biomedical research revised its strategy in view of a spurt in coronavirus cases in the country this week.

The new strategy aims to contain the spread of infection more effectively and to provide reliable diagnosis to all individuals meeting the inclusion criteria of COVID-19 testing.

The death toll due to the novel coronavirus rose to 169 and the number of cases climbed to 5,865 in the country on Thursday registering an increase of 591 cases since Wednesday, according to the Union Health Ministry.

However, a PTI tally of figures reported by various states as on Thursday showed at least 6624 cases and 225 deaths.

There has been a lag in the Union Health Ministry figures, compared to the number of cases and deaths announced by different states, which officials attribute to procedural delays in assigning the cases to individual states.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 09 2020 | 11:00 PM IST

Next Story